Cheng Cao
Impact in
- Biological Psychiatry top 10%
- Molecular Biology top 10%
- DNA Repair Mechanisms
- Ubiquitin and proteasome pathways
- Cancer therapeutics and mechanisms
- Redox biology and oxidative stress
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 5
- DNA Repair Mechanisms 4
- Ubiquitin and proteasome pathways 4
- Hematology 15
- Chronic Myeloid Leukemia Treatments 12
- Co-authors
- Donald Küfe (7 shared papers)Yumei Leng (5 shared papers)Xuan Liu (6 shared papers)Takeshi Shimizu (1 shared paper)Yves Pommier (1 shared paper)Kurt W. Kohn (1 shared paper)P M O'Connor (1 shared paper)Chenxi Yuan (5 shared papers)
- Journals
- Journal of Biological Chemistry (5 papers)Cell Cycle (2 papers)Biochemical and Biophysical Research Communications (2 papers)iScience (2 papers)eLife (2 papers)
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Cheng Cao
78 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 137
- Biological Psychiatry 43
- Molecular Biology 836
- Cell Biology 193
- Hematology 124
- Oncology 263
Countries citing papers authored by Cheng Cao
This map shows the geographic impact of Cheng Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Cao more than expected).
Fields of papers citing papers by Cheng Cao
This network shows the impact of papers produced by Cheng Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Cao. The network helps show where Cheng Cao may publish in the future.
Co-authors
The 25 scholars most cited alongside Cheng Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Abrogation of an S-phase checkpoint and potentiation of camptothecin cytotoxicity by 7-hydroxystaurosporine (UCN-01) in human cancer cell lines, possibly influenced by p53 function. | 1997 | 206 |
| 2 | 2003 | 157 | |
| 3 | 2003 | 108 | |
| 4 | 2003 | 92 | |
| 5 | 2016 | 91 | |
| 6 | 2015 | 65 | |
| 7 | 2016 | 62 | |
| 8 | 2001 | 55 | |
| 9 | 2021 | 53 | |
| 10 | 2006 | 50 | |
| 11 | 2021 | 48 | |
| 12 | 2014 | 45 | |
| 13 | 1992 | 45 | |
| 14 | 2014 | 44 | |
| 15 | 2016 | 38 | |
| 16 | 2009 | 37 | |
| 17 | 2010 | 35 | |
| 18 | 2003 | 34 | |
| 19 | 2022 | 32 | |
| 20 | 2020 | 29 |
About Cheng Cao
Cheng Cao is a scholar working on Molecular Biology, Hematology, Oncology, Immunology and Cell Biology, having authored 89 papers that have together received 1.8k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (12 papers), Microtubule and mitosis dynamics (7 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), Cancer-related Molecular Pathways (5 papers), DNA Repair Mechanisms (4 papers), Ubiquitin and proteasome pathways (4 papers), interferon and immune responses (4 papers) and Intracerebral and Subarachnoid Hemorrhage Research (4 papers). The work is most often cited by research in Biological Psychiatry (43 citations), Molecular Biology (836 citations), Cell Biology (193 citations), Hematology (124 citations) and Oncology (263 citations). Cheng Cao has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Donald Küfe, Yumei Leng, Xuan Liu, Takeshi Shimizu, Yves Pommier, Kurt W. Kohn, P M O'Connor, Chenxi Yuan, Shokei Kim‐Mitsuyama and Yu Hasegawa. Their work appears in journals such as Journal of Biological Chemistry, Cell Cycle, Biochemical and Biophysical Research Communications, iScience and eLife.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.